Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure
Clinical trial NCT07643025 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07643025
- Sponsor
- Dennis Kim
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2029-07-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.